Healthcare data science company Apixio Inc., today announced that it has raised $19.3 million in Series D funding led by SSM Partners with participation from First Analysis, Bain Capital Ventures and Apixio’s largest angel investor. Apixio will utilize the funding towards advancing and scaling products powered by its cognitive computing platform, further enabling insights for optimal patient care. Casey West, managing partner at SSM Partners will join the Board of Directors, bringing deep healthcare expertise and data science knowledge. The latest Series D round bring the company’s total funding to date at $41.88M.
News & Media
Our efforts to transform healthcare through powerful AI-driven technology are garnering a lot of attention in the media. Follow along with the revolution through our latest press releases and news stories.
Contact us for media inquiries.